News block test page

R&D shines in the spotlight in Budapest

Last week, we attended prestigious scientific, R&D-oriented events in Budapest. The 32nd Semmelweis Symposium focused on network medicine for future healthcare, mapping the most outstanding research results and breakthroughs in network sciences, systems biology and human dynamics. The multi-faceted approach to bioinformatics research pointed back to the EU summit in Budapest in early November, where R&D was given increased attention. The symposium was also an excellent opportunity to organize a face-to-face meeting within the REPO4EU project, resulting in crucial decisions. Let’s see what these meetings were all about. 32nd Semmelweis Symposium Thought-provoking presentations used different approaches to examine the human... Continue reading News block test page

REPO4EU and REMEDi4ALL met in Bruxelles

Last week, on October 30, Egnosis participated in the Drug Repurposing Cluster meeting in Brussels hosted by the European Health and Digital Executive Agency (HaDEA). This gathering served as a valuable touchpoint for Horizon Europe-funded projects REPO4EU and REMEDi4ALL, providing opportunities to showcase recent advancements and foster collaboration. EU project officer Monica Ensini commenced the tight agenda. In her warm, welcoming address, she outlined the significance and priority of the two named projects, as the expectations placed upon them are extremely high. Further, the coordinators—Harald H.H.W. Schmidt from REPO4EU, Anton Ussi and Donald Lo from REMEDi4ALL—presented the projects’ results so... Continue reading News block test page

WHAT'S NEW?

REPO4EU and REMEDi4ALL met in Bruxelles

Egnosis wins first place in R&D and Hight-tech

Egnosis earned first place in the Research and Development, and High-Tech category for small businesses for another consecutive year. This achievement highlights our commitment to quality, innovation, and excellence in the high-tech industry. The annual Awards Gala, hosted by the Covasna County Chamber of Commerce and Industry, celebrated the region’s most distinguished companies on October 24, 2024, at Kolcza Restaurant. Within the gala, performing companies from Covasna County were awarded in all major fields of industry in Romania. For Egnosis, this recognition reflects more than competitive success. It is a testament to our commitment to fostering a high-performing, forward-looking community... Continue reading News block test page

RExPO24 in Munich

Munich has not only been whizzing about the EURO2024 championship but also systems medicine, as last week hosted RExPO24, the 3rd International Conference on Systems Medicine, AI & Drug Repurposing, uniting experts and participants to form a robust drug-repurposing community. The Egnosis delegation was also present at the event. Besides, our colleague Balázs Orbán delivered a captivating presentation on the potential of precision drug repurposing through the RePo4EU unified platform. The RePo4EU unified platform Within REPO4EU, the Horizon Europe-funded research project, we aim to establish a first-in-class coherent and innovative web-based platform for safe and efficient drug repurposing for all... Continue reading News block test page

New project kickoff: dAIbetes

In a significant stride towards advancing precision medicine, a consortium coordinated by Prof. Dr. Jan Baumbach from the University of Hamburg (Germany), with 13 partners from seven countries, including Egnosis, has been awarded a prestigious Horizon Europe grant to develop a cutting-edge federated health data infrastructure. The project named “dAIbetes” is revolutionizing Type 2 diabetes care. It focuses on leveraging virtual twins as predictive tools in personalized disease management, targeting treatment outcomes in type2 diabetes. The project started on 01 January 2024. To develop virtual twins as prognostic tools for precision medicine the partners of dAIbetes will integrate extensive datasets... Continue reading News block test page